Holding(s) in Company
Calculus Capital Limited, acting on behalf of Rathbones plc, has notified Arecor Therapeutics Plc of a change in its major holding, increasing its voting rights from 5.31% to 6.37%, representing 2,403,404 voting rights. This notification is due to an event changing the breakdown of voting rights, with the threshold crossed on October 7, 2026, and the issuer notified on October 8, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your AREC notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
| An event changing the breakdown of voting rights | X |
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Calculus Capital Limited |
| City and country of registered office (if applicable) | 12 Conduit Street, London, W1S 2XH, UK |
Full name of shareholder(s) (if different from 3.) v
| Name | Rathbones plc |
| City and country of registered office (if applicable) | 30 Gresham Street, London, EC2V 7QN, UK |
| 5. Date on which the threshold was crossed or reached vi : | 07/10/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 08/10/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 6.37 | 6.37 | 2,403,404 |
| Position of previous notification (if applicable) | 5.31 | 5.31 | |
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| 2,403,404 | 5.31 | ||
| SUBTOTAL 8. A | 2,403,404 | 5.31 | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
In case of proxy voting, please identify:
| Name of the proxy holder | n/a |
| The number and % of voting rights held | n/a |
| The date until which the voting rights will be held | n/a |
| 11. Additional information xvi | |
| Place of completion | London, United Kingdom |
| Date of completion | 08/10/2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.